ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
出版年份 2020 全文链接
标题
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-06
DOI
10.1038/s41571-020-0392-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Circulating epigenetic biomarkers for detection of recurrent colorectal cancer
- (2020) Erin L. Symonds et al. CANCER
- Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
- (2020) Huiyan Luo et al. Science Translational Medicine
- Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
- (2019) Funda Meric-Bernstam et al. LANCET ONCOLOGY
- Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
- (2019) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
- (2019) Romain Meddeb et al. CLINICAL CHEMISTRY
- Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
- (2019) Yuxuan Wang et al. JAMA Oncology
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
- (2019) Thomas Reinert et al. JAMA Oncology
- Mismatch Repair–Proficient Colorectal Cancer: Finding the Right TiME to Respond
- (2019) Jason A. Willis et al. CLINICAL CANCER RESEARCH
- Use of Circulating Tumor DNA for Cancer Immunotherapy
- (2019) Alexandra Snyder et al. CLINICAL CANCER RESEARCH
- Intra‐individual variation of circulating tumour DNA in lung cancer patients
- (2019) Johanne A Hojbjerg et al. Molecular Oncology
- Liquid biopsy for rectal cancer: A systematic review
- (2019) Daniela Massihnia et al. CANCER TREATMENT REVIEWS
- Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
- (2019) Andrew Georgiadis et al. CLINICAL CANCER RESEARCH
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- (2019) Scott Kopetz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assay
- (2019) Sarabjot Pabla et al. Oncotarget
- 526PDTRIUMPH: Primary efficacy of a phase II trial of trastuzumab (T) and pertuzumab (P) in patients (pts) with metastatic colorectal cancer (mCRC) with HER2 (ERBB2) amplification (amp) in tumour tissue or circulating tumour DNA (ctDNA): A GOZILA sub-study
- (2019) Y Nakamura et al. ANNALS OF ONCOLOGY
- 529PDEarly identification of treatment effect by methylated circulating tumour DNA in metastatic colorectal cancer
- (2019) C B Thomsen et al. ANNALS OF ONCOLOGY
- 527PDTrastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial
- (2019) J H Strickler et al. ANNALS OF ONCOLOGY
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
- (2019) Shelize Khakoo et al. CLINICAL CANCER RESEARCH
- RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
- (2018) J B Bachet et al. ANNALS OF ONCOLOGY
- Detection of somatic RAS mutations in circulating tumor DNA from metastatic colorectal cancer patients: are we ready for clinical use?
- (2018) C Montagut et al. ANNALS OF ONCOLOGY
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens
- (2018) Eric A. Severson et al. BLOOD
- Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer
- (2018) Giulia Siravegna et al. CANCER CELL
- New Insights from Studies of Clonal Hematopoiesis
- (2018) Christopher J. Gibson et al. CLINICAL CANCER RESEARCH
- Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers With or Without Liver Metastases
- (2018) Wanxia Gai et al. CLINICAL CHEMISTRY
- Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
- (2018) Jeanne Tie et al. GUT
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
- (2018) Jonathan M Loree et al. JNCI-Journal of the National Cancer Institute
- NCCN Guidelines Insights: Colon Cancer, Version 2.2018
- (2018) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
- (2018) Maxime J M van der Valk et al. LANCET
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E -Mutant Colorectal Cancer
- (2018) Ryan B. Corcoran et al. Cancer Discovery
- Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
- (2018) Xin Wang et al. Oncotarget
- Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
- (2018) Caroline Vandeputte et al. Oncotarget
- Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
- (2018) Jonathan M Loree et al. JNCI-Journal of the National Cancer Institute
- Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
- (2018) Jenny H. Lee et al. JAMA Oncology
- Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
- (2018) Clara Montagut et al. JAMA Oncology
- Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC).
- (2018) Allan Andresson Lima Pereira et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
- (2018) Luc Cabel et al. Nature Reviews Clinical Oncology
- Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge
- (2018) C M Parseghian et al. ANNALS OF ONCOLOGY
- Cell-free DNA and preoperative chemoradiotherapy for rectal cancer: a systematic review
- (2018) Anders Kindberg Boysen et al. Clinical & Translational Oncology
- Circulating Tumor DNA–Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies
- (2018) Arvind Dasari et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced detection of circulating tumor DNA by fragment size analysis
- (2018) Florent Mouliere et al. Science Translational Medicine
- Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
- (2018) Joel Petit et al. JOURNAL OF SURGICAL RESEARCH
- Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
- (2017) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Biomarkers for the Evaluation of Colorectal Cancer
- (2017) Antonia R. Sepulveda et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions
- (2017) Lisanne F. van Dessel et al. Molecular Oncology
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression
- (2017) F Di Ruocco et al. ONCOGENE
- Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
- (2017) Elisa Lazzari et al. Nature Communications
- Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
- (2017) John H. Strickler et al. Cancer Discovery
- Genomic Analysis of Plasma Cell-Free DNA in Patients With Cancer
- (2017) Geoffrey R. Oxnard et al. JAMA Oncology
- Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma
- (2016) Dina El-Gayar et al. Asian Pacific Journal of Cancer Prevention
- Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes
- (2016) Qing Kang et al. CLINICAL BIOCHEMISTRY
- Hematopoietic Stem Cells Are the Major Source of Multilineage Hematopoiesis in Adult Animals
- (2016) Catherine M. Sawai et al. IMMUNITY
- A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
- (2016) Karen L. Reckamp et al. Journal of Thoracic Oncology
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
- (2016) Beth O. Van Emburgh et al. Nature Communications
- Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation
- (2016) D. S. Hong et al. Cancer Discovery
- Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
- (2016) Adrian G. Sacher et al. JAMA Oncology
- Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
- (2016) Inga Medina Diaz et al. PLoS One
- Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
- (2015) M. P. Morelli et al. ANNALS OF ONCOLOGY
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
- (2015) S. Arena et al. CLINICAL CANCER RESEARCH
- Preanalytical Variables Affecting the Integrity of Human Biospecimens in Biobanking
- (2015) C. Ellervik et al. CLINICAL CHEMISTRY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
- (2015) Yuxuan Wang et al. Science Translational Medicine
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients
- (2015) Seung Tae Kim et al. Oncotarget
- Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
- (2015) Richard B. Lanman et al. PLoS One
- Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
- (2014) T B Hao et al. BRITISH JOURNAL OF CANCER
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
- (2012) D. Santini et al. ANNALS OF ONCOLOGY
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
- (2012) Luis A. Diaz Jr et al. NATURE
- Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
- (2012) Clara Montagut et al. NATURE MEDICINE
- Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
- (2011) W. W. Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials
- (2009) Daniel Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Circulating Tumor DNA to Confirm Somatic KRAS Mutations
- (2009) Matthias Holdhoff et al. JNCI-Journal of the National Cancer Institute
- Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients
- (2008) Frank Diehl et al. GASTROENTEROLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now